Traumatic intracranial hemorrhage correlates with preinjury brain atrophy, but not with antithrombotic agent use: a retrospective study.

The impact of antithrombotic agents (warfarin, clopidogrel, ASA) on traumatic brain injury outcomes is highly controversial. Although cerebral atrophy is speculated as a risk for acute intracranial hemorrhage, there is no objective literature evidence.This is a retrospective, consecutive investigati...

Full description

Bibliographic Details
Main Authors: C Michael Dunham, David A Hoffman, Gregory S Huang, Laurel A Omert, David J Gemmel, Renee Merrell
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4184859?pdf=render
_version_ 1819067923264700416
author C Michael Dunham
David A Hoffman
Gregory S Huang
Laurel A Omert
David J Gemmel
Renee Merrell
author_facet C Michael Dunham
David A Hoffman
Gregory S Huang
Laurel A Omert
David J Gemmel
Renee Merrell
author_sort C Michael Dunham
collection DOAJ
description The impact of antithrombotic agents (warfarin, clopidogrel, ASA) on traumatic brain injury outcomes is highly controversial. Although cerebral atrophy is speculated as a risk for acute intracranial hemorrhage, there is no objective literature evidence.This is a retrospective, consecutive investigation of patients with signs of external head trauma and age ≥60 years. Outcomes were correlated with antithrombotic-agent status, coagulation test results, admission neurologic function, and CT-based cerebral atrophy dimensions.Of 198 consecutive patients, 36% were antithrombotic-negative and 64% antithrombotic-positive. ASA patients had higher arachidonic acid inhibition (p = 0.04) and warfarin patients had higher INR (p<0.001), compared to antithrombotic-negative patients. Antithrombotic-positive intracranial hemorrhage rate (38.9%) was similar to the antithrombotic-negative rate (31.9%; p = 0.3285). Coagulopathy was not present on the ten standard coagulation, thromboelastography, and platelet mapping tests with intracranial hemorrhage and results were similar to those without hemorrhage (p≥0.1354). Hemorrhagic-neurologic complication (intracranial hemorrhage progression, need for craniotomy, neurologic deterioration, or death) rates were similar for antithrombotic-negative (6.9%) and antithrombotic-positive (8.7%; p = 0.6574) patients. The hemorrhagic-neurologic complication rate was increased when admission major neurologic dysfunction was present (63.2% versus 2.2%; RR = 28.3; p<0.001). Age correlated inversely with brain parenchymal width (p<0.001) and positively with lateral ventricular width (p = 0.047) and cortical atrophy (p<0.001). Intracranial hemorrhage correlated with cortical atrophy (p<0.001) and ventricular width (p<0.001).Intracranial hemorrhage is not associated with antithrombotic agent use. Intracranial hemorrhage patients have no demonstrable coagulopathy. The association of preinjury brain atrophy with acute intracranial hemorrhage is a novel finding. Contrary to antithrombotic agent status, admission neurologic abnormality is a predictor of adverse post-admission outcomes. Study findings indicate that effective hemostasis is maintained with antithrombotic therapy.
first_indexed 2024-12-21T16:25:58Z
format Article
id doaj.art-4cfdc100b90a4e41aee09ee0530a8351
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T16:25:58Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-4cfdc100b90a4e41aee09ee0530a83512022-12-21T18:57:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01910e10947310.1371/journal.pone.0109473Traumatic intracranial hemorrhage correlates with preinjury brain atrophy, but not with antithrombotic agent use: a retrospective study.C Michael DunhamDavid A HoffmanGregory S HuangLaurel A OmertDavid J GemmelRenee MerrellThe impact of antithrombotic agents (warfarin, clopidogrel, ASA) on traumatic brain injury outcomes is highly controversial. Although cerebral atrophy is speculated as a risk for acute intracranial hemorrhage, there is no objective literature evidence.This is a retrospective, consecutive investigation of patients with signs of external head trauma and age ≥60 years. Outcomes were correlated with antithrombotic-agent status, coagulation test results, admission neurologic function, and CT-based cerebral atrophy dimensions.Of 198 consecutive patients, 36% were antithrombotic-negative and 64% antithrombotic-positive. ASA patients had higher arachidonic acid inhibition (p = 0.04) and warfarin patients had higher INR (p<0.001), compared to antithrombotic-negative patients. Antithrombotic-positive intracranial hemorrhage rate (38.9%) was similar to the antithrombotic-negative rate (31.9%; p = 0.3285). Coagulopathy was not present on the ten standard coagulation, thromboelastography, and platelet mapping tests with intracranial hemorrhage and results were similar to those without hemorrhage (p≥0.1354). Hemorrhagic-neurologic complication (intracranial hemorrhage progression, need for craniotomy, neurologic deterioration, or death) rates were similar for antithrombotic-negative (6.9%) and antithrombotic-positive (8.7%; p = 0.6574) patients. The hemorrhagic-neurologic complication rate was increased when admission major neurologic dysfunction was present (63.2% versus 2.2%; RR = 28.3; p<0.001). Age correlated inversely with brain parenchymal width (p<0.001) and positively with lateral ventricular width (p = 0.047) and cortical atrophy (p<0.001). Intracranial hemorrhage correlated with cortical atrophy (p<0.001) and ventricular width (p<0.001).Intracranial hemorrhage is not associated with antithrombotic agent use. Intracranial hemorrhage patients have no demonstrable coagulopathy. The association of preinjury brain atrophy with acute intracranial hemorrhage is a novel finding. Contrary to antithrombotic agent status, admission neurologic abnormality is a predictor of adverse post-admission outcomes. Study findings indicate that effective hemostasis is maintained with antithrombotic therapy.http://europepmc.org/articles/PMC4184859?pdf=render
spellingShingle C Michael Dunham
David A Hoffman
Gregory S Huang
Laurel A Omert
David J Gemmel
Renee Merrell
Traumatic intracranial hemorrhage correlates with preinjury brain atrophy, but not with antithrombotic agent use: a retrospective study.
PLoS ONE
title Traumatic intracranial hemorrhage correlates with preinjury brain atrophy, but not with antithrombotic agent use: a retrospective study.
title_full Traumatic intracranial hemorrhage correlates with preinjury brain atrophy, but not with antithrombotic agent use: a retrospective study.
title_fullStr Traumatic intracranial hemorrhage correlates with preinjury brain atrophy, but not with antithrombotic agent use: a retrospective study.
title_full_unstemmed Traumatic intracranial hemorrhage correlates with preinjury brain atrophy, but not with antithrombotic agent use: a retrospective study.
title_short Traumatic intracranial hemorrhage correlates with preinjury brain atrophy, but not with antithrombotic agent use: a retrospective study.
title_sort traumatic intracranial hemorrhage correlates with preinjury brain atrophy but not with antithrombotic agent use a retrospective study
url http://europepmc.org/articles/PMC4184859?pdf=render
work_keys_str_mv AT cmichaeldunham traumaticintracranialhemorrhagecorrelateswithpreinjurybrainatrophybutnotwithantithromboticagentusearetrospectivestudy
AT davidahoffman traumaticintracranialhemorrhagecorrelateswithpreinjurybrainatrophybutnotwithantithromboticagentusearetrospectivestudy
AT gregoryshuang traumaticintracranialhemorrhagecorrelateswithpreinjurybrainatrophybutnotwithantithromboticagentusearetrospectivestudy
AT laurelaomert traumaticintracranialhemorrhagecorrelateswithpreinjurybrainatrophybutnotwithantithromboticagentusearetrospectivestudy
AT davidjgemmel traumaticintracranialhemorrhagecorrelateswithpreinjurybrainatrophybutnotwithantithromboticagentusearetrospectivestudy
AT reneemerrell traumaticintracranialhemorrhagecorrelateswithpreinjurybrainatrophybutnotwithantithromboticagentusearetrospectivestudy